HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 283, Issue 23, 16068-16076, June 6, 2008

This Article Abstract Full Text (PDF) Supplemental Data All Versions of this Article: 283/23/16068    most recent M801991200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ding, Y. Articles by Sherman, D. H. Search for Related Content PubMed PubMed Citation Articles by Ding, Y. Articles by Sherman, D. H. Social Bookmarking                      What's this?

Molecular Analysis of a 4-Dimethylallyltryptophan Synthase from Malbranchea aurantiaca^*

Yousong Ding, Robert M. Williams^¶, and David H. Sherman¹

From the Life Sciences Institute and Departments of Medicinal Chemistry, Microbiology & Immunology, and Chemistry, University of Michigan, Ann Arbor, Michigan 48109 and the ^¶Department of Chemistry, Colorado State University, Fort Collins, Colorado 80523 and the University of Colorado Cancer Center, Aurora, Colorado 80045

Received for publication, March 12, 2008

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Prenyltransferases are widely distributed in prokaryotes and eukaryotes and play critical roles in cell signaling, protein trafficking, and elaboration of complex molecules in secondary metabolism. Numerous prenylated natural products have been isolated from diverse microorganisms, including bacteria and fungi. These complex metabolites possess a wide range of biological activities, with some showing promise as medicinal agents. On the other hand, many prenylated secondary metabolites have been described as toxins such as ergot alkaloids that have potent psychotropic activity. We have characterized a new prenyltransferase isolated from genomic DNA of Malbranchea aurentiaca RRC1813. Enzyme specificity was investigated with a series of amino acid substrates revealing its function as a 4-dimethylallyltryptophan synthase. Polypeptide sequence alignment analysis showed that it groups with a new class of prenyltransferase enzymes that lack the typical (N/D)DXXD motif found in these polypeptides. MaPT activity was not dependent on a divalent cation cofactor, although it was reversibly inactivated by 5 mM EDTA. Analysis of kinetic parameters showed reduced enzyme efficiency upon simple modification of L-Trp. Moreover, D-Trp had 0.5% relative activity and functioned as a competitive inhibitor with a K_i of 40.41 µM. Finally, Thr-105, Asp-179, Lys-189, and Lys-261 in MaPT were serially mutated, and the resulting lesions displayed low or complete loss of activity. This study provides a detailed characterization of a prenyltransferase in Malbranchea species, reveals two enzyme inhibitors, and through site-directed mutagenesis identified several key amino acid residues in catalysis, yielding new insights into this important yet understudied class of natural product biosynthetic enzymes.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Fungi are phylogenetically diverse microorganisms that produce thousands of low molecular weight natural products. A significant number of these metabolites are in clinical use as human therapeutics, including antibacterial penicillins, cephalosporins, immunosuppressive cyclosporine A, and cholesterol-lowering HMG-CoA reductase inhibitor "statins" (1). However, drug-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis continue to emerge as a threat to human health (2-4). Along with medical needs to treat a spectrum of diseases, an increasing number of natural products have been isolated from fungal sources and screened for potential bioactive secondary metabolites (5). Recently, new natural products like malbranicin, dihydromalbranicin, penicillic acid, and malbrancheamide A with promising bioactivity profiles have been isolated from Malbranchea aurentiaca and other related species (6-10). Our efforts have focused broadly on the secondary metabolome of this strain for isolation of natural products and elucidation of the putative malbrancheamide and ergot alkaloid gene clusters. These efforts have led to the identification of a new prenyltransferase (PT)² whose characterization is the subject of this report.

PTs are a family of enzymes that catalyze prenyl transfer to a variety of acceptors including isoprenoids, aromatics groups, and specific amino acid residues of proteins to produce over 50,000 metabolites (11, 12). These compounds are critical in biological processes of bacteria, plants, and animals. PTs are classified into three main groups based on their catalytic function (11). The first class is comprised of isoprenyl diphosphate (IPP) synthases that uses IPP as a building block to produce different length allylic diphosphates. Enzymes in this class share relatively high identities and have two conserved (N/D)DXXD sequence motifs for binding substrate and require Mg²⁺ as cofactor (13). According to the stereochemical outcome of reaction products, this enzyme class is further divided into trans- and cis-PTs (11). The second class of PT utilizes proteins as their substrates and catalyzes farnesylation at a CaaX motif located at the G-protein C terminus with Zn²⁺ as cofactor. There is considerable evidence that dysfunction of this class of PTs plays a role in malignant transformation of cells (14). The last class of PTs catalyze cyclization of farnesyl diphosphate (FPP) or geranylgeranyl diphosphate in a Mg²⁺-dependent manner to produce numerous isoprenoid natural products (15, 16). This class of enzymes also contains a conserved (N/D)DXXD sequence motif.

Recently, a new group of PTs has been isolated and biochemically characterized from Streptomyces sp., Lyngbya majuscula, and the fungus Aspergillus sp (17-27). There are several significant differences between this class and the trans-PTs/aromatic PTs that are membrane associated and contain the (N/D)DXXD motif (28). First, these enzymes (exemplified by CloQ, LtxC, FgaPT1, FgaPT2, FtmPT1, and TdiB) do not have the presumed prenyl diphosphate binding motif (N/D)DXXD (17, 18, 20, 23, 25, 26), suggesting a different substrate binding mechanism. Second, these new PTs (except Orf2) function in the absence of a divalent cation such as Mg²⁺, Mn²⁺, and Zn²⁺ (29). Finally, Orf2 from Streptomyces sp. strain CL190 has a unique three-dimensional structure compared with previously described prenyltransferases (29). This novel PT barrel presumably represents the core structure of all other PTs in this class. From a chemical reaction point of view, these new PTs commonly catalyze C-C bond formation but some like Fnq26 and TdiB also specify formation of a C-O bond (17, 21). Furthermore, Fnq26 and TdiB catalyze both standard and reverse prenyl transfer reactions, a characteristic that is unique to this new class.

Herein, we report a new member of this class of PTs isolated from the fungus M. aurentiaca (named M. aurantiaca PT (MaPT)). The polypeptide was characterized by performing a substrate specificity and metal ion dependence profile, enzyme kinetic analysis, and site-directed mutagenesis that revealed four amino acid residues important for enzyme catalysis and identification of two MaPT inhibitors.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Materials—DMAPP was purchased from Sigma-Aldrich or Isoprenoids. Buffer components and other reagents were purchased from Sigma-Aldrich or Thermo Fisher Scientific.

Analytical Methods—A Beckman Coulter HPLC, fitted with an XBridge^TM C18 column (5 µm, 4.6 x 250 mm), coupled with a System Gold I68 Detector was routinely used for HPLC-UV analysis. The detection wavelength was set at 269 nm. A linear gradient of 20-70% acetonitrile in 0.1% trifluoroacetic acid over 20 min was used for product detection. One 10-min re-equilibration program with 20% acetonitrile in 0.1% trifluoroacetic acid followed each run. A SHIMADZU LCMS-2010EV system was used for LC-MS analysis with a linear gradient of 20-80% acetonitrile in 0.1% FA over 15 min. An XBridge^TM C18 (3.5 µm, 2.1 x 150 mm) column was used with a flow rate of 208 µl/min. Varian Inova 500 MHz or Bruker DRX 500 MHz instruments were used to record NMR spectra. VG (Micromass) 70-250-S Magnetic Sector Mass Spectrometer in ESI⁺ mode was used to record high resolution mass spectra.

Bacterial Strains, Culture Conditions, and DNA Manipulation—Escherichia coli DH5 and BL21(DE3) (Novagen) were grown in Luria-Bertani (LB) broth or on LB agar for gene cloning and protein expression, respectively. M. aurantiaca RRC1813 was grown at 28 °C, 180 rpm in the dark. Standard methods for DNA isolation and manipulation were performed as described by Sambrook and Russel (30). Genomic DNA from M. aurantiaca RRC1813 was isolated with the MasterPure Yeast DNA Purification kit (Epicenter Biotechnologies) as described in the manual. Restriction enzymes and T4 DNA ligase were purchased from New England Biolabs. DNA sequencing was performed by the University of Michigan DNA Sequencing Core facility using an ABI Model 3730 sequencer. The MaPT Gen-Bank^TM accession numbers are EU420001 [GenBank] for its genomic DNA and EU420002 [GenBank] for its putative cDNA.

Isolation of the MaPT Gene—Degenerate primers were designed from conserved sequences of the new class of PTs. The pair of PT-FW and PT-RV primers was used to screen putative PTs from isolated M. aurantiaca RRC1813 genomic DNA by PCR (supplemental Table S1). Fragments of about 750 bp were subcloned into the pGEM-Teasy vector (Promega) and sequenced. BLASTX in NCBI was used to identify sequenced PT fragments. TAIL-PCR was applied to amplify fragments extended from both ends of the PT gene to produce full-length genomic DNA (31). The long specific primers were designed on the known sequence, while two arbitrary primers were first used by Liu and Whittier (31). All primers used in TAIL-PCR are listed in the supplemental Table S1. BCM Gene Finder was used to predict putative introns in the full-length PT gene. A 63-bp intron was predicted and removed with primers of InterFW and InterRV along with PTFW(NdeI) and PTRV-(BamHI) to produce the MaPT cDNA (supplemental Table S1).

Gene Cloning, Expression, and Protein Purification—The purified MaPT cDNA were ligated to pET28a to produce pET28a-MaPT for transformation of E. coli DH5 competent cells. The construct was isolated and submitted for sequencing to exclude mutations introduced during PCR amplification and gene manipulation. The construct was transferred into E. coli BL21 (DE3) competent cells for protein expression. Cells harboring the construct were cultured in 4 liters of LB medium containing 25 µg/ml of kanamycin and grown at 37 °C in a shaker at 200 rpm until an A₆₀₀ reached 0.6. The cultures were then induced by IPTG with a final concentration of 0.2 mM. The cultures were further grown at 16 °C in a shaker at 180 rpm for 16 h. The cells were harvested by centrifugation (7250 x g, 12 min, and 4 °C), and cell pellets were stored in -80 °C or directly used for protein purification. Cell pellets from a 4-liter culture were resuspended in 50 ml of lysis buffer (1x PBS, 3 mM β-mercaptoethanol (BME), 10% glycerol, 20 mM imidazole, pH 7.4), which was sonicated to release soluble proteins. The supernatant after centrifugation at 35,000 x g at 4 °C for 36 min was incubated with 5 ml of pre-equilibrated Ni-NTA-agarose resin (Qiagen) at 4 °C for 2 h. The resin was then washed with 150 ml of lysis buffer, and recombinant His₆-MaPT was eluted with 10 ml of 200 mM imidazole in 1x PBS (pH 7.4), 3 mM BME, and 10% glycerol. The protein was further purified with Superdex 200 column (Amersham Biosciences) with gel chromatography running buffer (1x PBS, 1 mM dithiothreitol, 10% glycerol, pH 7.4). Protein absorbance at 280 nm was measured for calculating its concentration with an extinction coefficient of 88490. The protein was then aliquoted and stored at -80 °C. The final yield of His₆-MaPT was 2.5 mg/liter.

Preparation of MaPT Mutants—MaPT gene mutants were prepared following the protocols from Stratagene QuikChange® II site-directed mutagenesis kit. The mutagenesis primers are shown in supplemental Table S1. The same procedures for the preparation of wild-type MaPT were followed to produce its mutants except that only Ni-NTA-agarose resin was used for protein purification.

Protein Analysis—Subunits of MaPT were analyzed by 4-12% SDS-PAGE, and protein bands were stained with Coomassie Brilliant Blue R-250. The molecular weight of MaPT with the His₆ tag at its N terminus was determined by Superdex 75 column (Amersham Biosciences) with gel chromatography running buffer. The column was calibrated with bovine serum albumin (66 kDa), chicken egg ovalbumin (43 kDa), bovine trypsinogen (25 kDa), and ribonuclease A (13. 7 kDa). The molecular mass of MaPT was calculated as 61.6 kDa.

Enzyme Assays—The 100-µl reaction mixture routinely contained 5 mM MgCl₂, 0.25 mML-Trp, 0.2 mM DMAPP, and 1 µl of 0.86 µg/µl MaPT in reaction buffer (1x PBS, pH 7.4, 10% glycerol, and 3 mM BME). Enzyme reactions were initiated by adding MaPT after prewarming the other components at 30 °C for 1 min and then kept at 30 °C for 30 min. Enzyme boiled at 100 °C for 10 min was used as a negative control. In the mutagenesis studies, MaPT mutants were used as the enzyme source. The reaction was stopped with 10 µl of 1.5 M trichloroacetic acid. The mixture was agitated well and centrifuged at 13,000 x g for 5 min. The enzyme products were detected by HPLC. To investigate substrate specificity, L-Trp was substituted with a series of derivatives. IPP, GPP, or FPP also substituted DMAPP in the reactions.

Metal Dependence of MaPT—5 mM of divalent metal ions (Mg²⁺, Ca²⁺, Mn²⁺, Fe²⁺, Co²⁺, Ni²⁺, Cu²⁺, Zn²⁺, and Sn²⁺) were added to the routine reaction mixture. 5 mM EDTA, EGTA, EDDA, and DHPTA were added to the reaction buffer containing 0.86 µg of MaPT, and the mixture was incubated at 30 °C for 5 min. Then 0.25 mML-Trp and 0.2 mM DMAPP were added to bring the volume to 100 µl and initiate the reaction, which was further incubated at 30 °C for 30 min before terminating with 10 µl of 1.5 M trichloroacetic acid. The products were detected by HPLC, and experiments were performed in duplicate.

Optimal Conditions for Enzyme Reaction—For investigation of optimal temperature, reactions were conducted under 4, 15, 23, 30, 37, and 42 °C in the reaction buffer described above. For investigation of optimal reaction buffer pH value, 50 mM Tris-Cl, or sodium phosphate with various pH values (5, 6, 7, 7.4, 8, 9, and 10) were used in the reactions at 30 °C. The same procedure for routine enzyme assay was followed in this section.

Kinetics Analysis—To find suitable MaPT concentration linearly correlated with product generation, 0.1, 0.25, 0.5, 1, 2, 4, and 8 µl of 0.86 µg/µl enzyme was added to reaction mixtures. The reaction was incubated at 30 °C for 6 min before terminating with 10 µl of 1.5 M trichloroacetic acid. To determine the time course of enzyme reactions, 50 µl of reaction mixture was removed and mixed with 5 µl of 1.5 M trichloroacetic acid at 1, 3, 5, 8, 12, 16, 20, 25, 30, and 35 min. The enzyme product was detected with the same method described above.

Reaction mixtures in the enzyme kinetic analysis contained 0.22 µg of MaPT, and 5 mM MgCl₂. To determine kinetic parameters of L-Trp, 5-OH-L-Trp, and L-abrine, 0.2 mM DMAPP was included in the reaction and 2-600 µM L-Trp, 5-1500 µM 5-OH-L-Trp, or 5-1000 µML-abrine was added. To determine kinetic parameters of DMAPP, 0.25 mML-Trp, 2 mM 5-OH-L-Trp, or 1 mM L-abrine was included in the reaction while DMAPP final concentration was varied (1-100, 5-200, and 5-160 µM, respectively). The reaction mixtures without L-Trp, 5-OH-L-Trp, L-abrine, or DMAPP were prewarmed at 30 °C for 1 min. The reactions were initiated by mixing them with the single omitted component and were further incubated at 30 °C for 5 and 6 min for L-Trp and 5-OH-L-Trp or L-abrine, respectively, before terminating with 10 µl of 1.5 M trichloroacetic acid. The mixtures were mixed well and centrifuged at 13,000 x g for 5 min. A 100-µl solution was subjected to HPLC for product detection. All experiments were performed in duplicate. The area under the product peak was measured, and the peak content amount was calculated using a dimethylallyltryptophan (DMAT) standard curve. The initial rate was calculated with equation of product (nmol)/100 µl x 110 µl/100 µl. The data were fit to the Michaelis-Menten equation or the substrate inhibition equation (v = V_max[S]/(K_m + [S](1+[S]/K_s)). For the competitive kinetic analysis, 0-100 µM D-Trp was included in the reactions containing varied concentration of L-Trp or DMAPP. 100 µML-Phe was also used as the putative inhibitor in the assay.

Characterization of Enzyme Reaction Products—2-ml reaction mixtures containing 2 mg of L-Trp, 5-OH-L-Trp, 5-Me-DL-Trp, or L-abrine and 1.2 mg of DMAPP were incubated at 30 °C overnight and stopped by adding 200 µl of 1.5 M trichloroacetic acid. The mixtures were mixed well and centrifuged at 13,000 x g for 5 min. The products were separated by a semi-preparative XBridge^TM C18 column with the same program except using a flow rate of 3 ml/min. The isolated products were lyophilized and subjected for ¹H and ¹³C NMR analyses and high resolution MS analysis (HRMS).

Analysis of Metal Content of MaPT—Twelve divalent metal ions (Mg²⁺, Ca²⁺, V²⁺, Cr²⁺, Mn²⁺, Fe²⁺, Co²⁺, Ni²⁺, Cu²⁺, Zn²⁺, Cd²⁺, Pb²⁺) in MaPT were detected by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) (Finnigan) in the Department of Geological Science, University of Michigan. The gel chromatography running buffer was used as the blank sample. All detected metal ion content measurements except Ni²⁺ were <0.05 mol per mol of MaPT.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Identification and Purification of MaPT—Several PT amino acid sequences were aligned to identify conserved regions for PT gene degenerate primer design in M. aurantiaca RRC1813 (Fig. 1A). A 750-bp fragment was isolated and predicted to be a dimethylallyltryptophan synthase (DMATS) based on sequence comparisons (data not shown). TAIL-PCR was subsequently applied to isolate the 1371-bp full-length MaPT genomic DNA (31). A 63-bp intron was predicted in the MaPT genomic DNA (BCM Gene Finder) and removed to produce the corresponding MaPT cDNA. The PT encoded from this cDNA was aligned with DMATSs from A. fumigatus (EAL94103 [GenBank] ), Balansia obtecta (Q6X1E1), Claviceps fusiformis (Q12594 [GenBank] ), C. purpurea (Q9C141), and Neotyphodium coenophialum (Q6X2E1), FgaPT1 (EAL94098 [GenBank] ), FgaPT2 (AAX08549 [GenBank] ), and FtmPT2 (Fig. 1A) (20). It shares two conserved regions for designing degenerate primers with other PTs and has the highest sequence identity with FgaPT2 (64%). The lack of a conserved (N/D)DXXD motif in this PT from M. aurantiaca RRC1813 indicated that this enzyme is a member of a recently identified new class of PTs.

View larger version (58K): [in this window] [in a new window]   FIGURE 1. Preparation of prenyltransferase (MaPT) from M. aurantiaca RRC1813 and HPLC analysis of enzyme reactions. A, alignment analysis of several members of the new class of PTs. Two motifs were identified for designing degenerate primers. Lanes 1-5 represent DMATS from A. fumigatus, B. obtecta, C. fusiformi, C. purpurea, and N. coenophialum, respectively. Lanes 6-9 are FgaPT1, FgaPT2, FtmPT2, and MaPT, respectively. B, 4-12% SDS-PAGE analysis of purified MaPT. Lane 1, molecular marker; lane 2, IPTG-uninduced total protein fraction; lane 3, IPTG-induced total protein fraction; lane 4, enzyme purified with Ni-NTA-agarose; lane 5, enzyme purified with gel chromatography. The purified enzyme showed an expected molecular mass of 51 kDa. C, HPLC analysis of enzyme reactions. Lane 1, authentic DMAT; lane 2, negative control with boiled enzyme used in the reaction; lane 3, MaPT enzyme reaction mixture. The product was analyzed by MS and showed an expected m/z value of mono-prenylated L-Trp. The retention times of L-Trp and enzyme product were 5.4 min and 12.5 min, respectively.

Enzyme Activity and Substrate Selectivity—L-Trp and a dipeptide, brevianamide F, were first tested as enzyme substrates. Brevianamide F was utilized by the enzyme with very poor conversion (see Table 1), whereas L-Trp was converted effectively into product, demonstrating it to be a more acceptable enzyme substrate (Table 1 and Fig. 1C). The m/z of the product corresponds to the theoretical weight of DMAT, suggesting the enzyme to be a DMATS. This result further confirms that DMATS is an enzyme common in many fungal strains such as Aspergillus sp., Balansia sp., Claviceps sp., Neotyphodium sp., and the newly isolated Malbranchea sp. MaPT was specific for DMAPP as no product was detected by LC-MS when L-Trp and brevianamide F were tested with IPP, GPP, and FPP (data not shown).

View larger version (16K): [in this window] [in a new window]   FIGURE 2. Four identified MaPT products. Four different enzyme substrates were converted into corresponding products in large scale enzyme reactions. The products were isolated by semi-prep HPLC and subjected to 1H and 13C NMR analyses and high resolution MS analysis (HRMS).

Five substrates used in this study contained side chains with variant electronegativity at C-5 of the L-Trp indole ring. 5-OH-L-Trp was the best substrate with 17.0 ± 0.37% relative activity, followed by 5-Me-DL-Trp (16.1 ± 0.01%), 5-MeO-DL-Trp (0.7 ± 0.02%), and 5-Br-DL-Trp (0.3 ± 0.02%), while 5-F-DL-Trp was not utilized by the enzyme. Thus, electronegativity of the side chain substituent on the L-Trp indole ring was critical for enzyme catalytic efficiency. Interestingly, FgaPT2 exhibits the same trend toward these five substrates, suggesting it is common to other DMATSs (24).

Identification of MaPT Enzyme Reaction Products—Products formed by reaction of MaPT with L-Trp, L-abrine, 5-OH-L-Trp, and 5-Me-DL-Trp in large scale reactions were purified by semi-preparative HPLC and analyzed by ¹H and ¹³C NMR and HRMS (Fig. 2). ¹H NMR analysis of the MaPT reaction with L-Trp revealed that a dimethylallyl group was appended at C-4 of the indole ring (supplemental Table S2). HRMS analysis of this product showed an ion with the m/z of 273.1610, which corresponds to the theoretical mass [M+H]⁺ (273.1603) of prenylated tryptophan. Further analysis of products with 5-OH-L-Trp, 5-Me-DL-Trp, and L-abrine as enzyme substrates confirmed C-4 of indole as the site for covalent linkage of the dimethylallyl group (supplemental Table S2). ¹³C NMR analysis provided additional evidence to confirm the structures of 4-prenylated L-abrine, 5-OH-L-Trp, and 5-Me-DL-Trp (see supplemental data). These three products also showed expected m/z values in the HRMS analysis.

Metal Dependence of MaPT—The optimal temperature and pH value for enzyme reactions were 30 °C and 7.4, respectively (supplemental Fig. S2). The product in the reaction including L-Trp was produced to be correlated linearly with up to 0.43 µg of proteins per 100-µl assay, and up to 12 min under the above optimal conditions. The enzyme activity was not dependent on any additive divalent cation while addition of 5 mM of Mg²⁺ or Ca²⁺ slightly enhanced MaPT activity by about 130% (supplemental Fig. S3). Five divalent metal ions (Mn²⁺, Fe²⁺, Co²⁺, Ni²⁺, and Zn²⁺) at 5 mM inhibited the enzyme activity from 50 to 80% and 5 mM of Cu²⁺ or Sn²⁺ significantly reduced enzyme activity to less than 10%. EDTA was found to hinder enzyme activity in a concentration-dependent manner (supplemental Fig. S3). More than 4 mM EDTA totally abrogated enzyme activity after incubating it with the enzyme at 30 °C for 5 min, this was not restored by addition of 10 mM Mg²⁺.

Cation dependence in prenyltransferases has been well documented and represents a key feature of the mechanistic biochemistry in these enzymes. Therefore, divalent cation content in MaPT was investigated with ICP-MS (see "Experimental Procedures"). Although Ni²⁺ concentration (1.62 µM in 17 µM MaPT solution) was increased about 26 times, all other metal ion content values were not changed, and found to be <0.05 mol per mol of MaPT. The increased Ni²⁺ content was presumed to be derived from Ni-NTA agarose used in protein purification. Therefore, purified MaPT contained none of the typical metal ion cofactors, and EDTA presumably exhibited its inhibition through a mechanism that is independent of divalent cation sequestration. Enzyme inhibition by EDTA was further investigated with related analogues including EGTA, EDDA, DHPTA, and EDTA-Mg²⁺ complex (Fig. 3A). Dialysis of the enzyme solution with 5 mM EDTA against reaction buffer regenerated active enzyme whose efficiency was similar to the positive control (Fig. 3B), demonstrating EDTA as a reversible inhibitor of MaPT. Interestingly, 5 mM EDTA was also reported to reduce CloQ prenyltransferase activity to 25% (23), and inhibits horseradish peroxidase, human liver arginase, and lignin peroxidase H2 in a metal ion-independent manner (32-34).

View larger version (19K): [in this window] [in a new window]   FIGURE 3. Reversible inhibition of MaPT activity by EDTA. A, inhibition of EDTA analogues to MaPT. 5 mM of each chemical was incubated with the enzyme at 30 °C for 5 min before initiating the reaction. All experiments were performed in duplicate. B, regaining enzyme activity by dialysis. 5 mM EDTA was incubated with MaPT at 30 °C for 5 min, and then dialyzed against gel chromatography running buffer at 4 °C overnight. Line 1, reaction with 1 mM L-Trp and dialyzed MaPT treated with EDTA; line 2, reaction with 1 mML-Trp and dialyzed MaPT untreated with EDTA. Mg2+ was not added to either reaction.

Mutagenesis of MaPT—The MaPT amino acid sequence was aligned to Orf2, CloQ, and NovQ sequences by ESPript (supplemental Fig. S4). MaPT Lys-261 (corresponding to Asn-173 in Orf2) was identified as a possible key residue involved in DMAPP binding. This residue was mutated to Glu and Leu (supplemental Fig. S5). MaPT K261E was highly soluble and readily purified while its K261L form was only partially purified due to significant insolubility. No product was generated in either reaction, reflecting the potential key role of Lys-261 in enzyme catalysis (Fig. 5). MaPT Lys-189 (the counterpart of Lys-119 in Orf2) was also presumed to be involved in diphosphate binding. Both MaPT K189E and K189L retained only 1.1 and 0.9% of wild-type enzyme activity, respectively (supplemental Fig. S5 and Fig. 5). Thus, this residue is also a key candidate involved in enzyme catalysis. Crystal structure analysis revealed that Ser-51 in Orf2 is involved in substrate binding through a hydrogen bond. A similar residue Thr-105 is found in MaPT, while two basic residues are present in CloQ, NovQ, and Fnq26. These positively charged residues have been suggested to act as surrogate of Mg²⁺ for -phosphate binding. The key residues for Mg²⁺ binding in Orf2 are Asp-62 and Asp-110. Although Asp-62 is not a conserved residue, Asp-110 is seemingly conserved among these PTs, casting some doubt on a role limited to metal binding. In this study, MaPT Thr-105 was mutated to Asp and Val while Asp-179 (corresponding to Asp-110 in Orf2) was mutated to Asn, Glu, and Val (supplemental Fig. S5). MaPT T105V retained about 11% of wild-type enzyme activity while the T105D mutant form was almost completely inactive (1.4% of wild-type MaPT) (Fig. 5). Considering Ser-51 in Orf2 also points toward the GPP-binding pocket (5-7-Å distance), this result suggests that Thr-105 along with other hydrophobic residues possibly defines a binding pocket for DMAPP. MaPT D179N, D179E, and D179V retained 40, 25, and 7% of wild-type enzyme activity, respectively.

View larger version (32K): [in this window] [in a new window]   FIGURE 4. MaPT reaction with L-Trp as substrate was inhibited by varying concentrations of D-Trp. Line 1, the Michaelis-Menten curve resulting from reactions in the presence of 100 µML-Phe; lines 2-5, the Michaelis-Menten curve generated by reactions in the presence of 0, 10, 50, and 100 µMD-Trp, respectively. The right inset graph is the plot of Km,obs versus [D-Trp] to provide the Ki value.

View larger version (21K): [in this window] [in a new window]   FIGURE 5. HPLC analysis of reaction products using mutant forms of MaPT and L-Trp as substrate. All reactions were run with the same reaction components and conditions. Addition of 0.86 µg of MaPT mutants except K261L initiated the reactions, which were incubated at 30 °C for 30 min before termination. Instead, 11.7 µg of partially purified MaPT K261L were used in the reaction. Peaks with low levels of product are labeled with black asterisks.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

MaPT consists of 435 amino acids that share high sequence similarity to FagPT2 and DMATSs from Aspergillus sp., Balansia sp., Claviceps sp., and Neotyphodium sp. (Fig. 1). These enzymes belong to a new class of PTs including CloQ, involved in the biosynthesis of chlorobiocin (23). MaPT does not contain the (N/D)DXXD motif, the characteristic feature of this class of PTs. The enzyme efficiently converted L-Trp into DMAT without addition of any divalent metal ion, although its activity was enhanced by adding 5 mM Mg²⁺ or Ca²⁺. However, this conversion was totally eliminated after incubating 17 µM enzyme with 4 mM EDTA, which was reversible upon dialysis. The mechanism of this type of EDTA inhibition remains unclear. In a H101N variant of human liver arginase, EDTA exhibited a predominant competitive inhibition, and its carboxylic acid group was presumably important for this effect (34). EDTA was also shown to be a competitive inhibitor of horseradish peroxidase by acting as an electron donor to compete with substrate iodine (33). Moreover, Chan and Anthony (39) found that EDTA bound to lysyl or arginyl residues near the cytochrome-binding domain of methanol dehydrogenase. X-ray crystal studies of MaPT will likely provide details about EDTA inhibition of this enzyme.

Our studies have demonstrated that the MaPT catalytic activity is affected by several possible factors relating to substrate structure. The first factor is the specific chirality of Trp. MaPT exhibited 0.5% relative activity toward D-Trp compared with L-Trp, and the unnatural amino acid acted as an inhibitor, the first identified competitive inhibitor for this new class of PTs (Table 1 and Fig. 4). This observation suggests that the reported kinetic parameters of FgaPT2 toward substrates containing both D- and L-configuration might require further refinement (24). Second, Gebler et al. (40) found that substituents with increasing electron-withdrawing property at the C-7 position of the indole ring decreased the turnover of DMATS from C. purpurea. In the current study, the electronegativity of substituents has a similar affect on MaPT catalytic ability. 5-OH-L-Trp was the best substrate with the highest relative enzyme activity, while no product was detected by LC-MS in the reaction with 5-F-DL-Trp as substrate. Third, the regiochemistry of methylation on the indole ring was also important for enzyme activity. 6-Me-DL-Trp was a better MaPT substrate than 5-Me-DL-Trp, while 1-Me-L-Trp served most poorly. Fourth, the modifications on amino or carboxylic acid group of L-Trp also affected enzyme activity, exemplified with relative activities of L-abrine, Ala-Trp, brevianamide F, and N-(2,4-dinitrophenyl)-L-Trp. Finally, an intact indole ring is important for enzyme catalysis. In the competitive analysis, L-Phe presumably did not bind to the same binding pocket of L-Trp because it had no effect on L-Trp kinetics compared with D-Trp. MaPT did not accept either L-His or L-Tyr as substrates.

The size of fungal enzymes in the new class of PTs such as FgaPT2 and MaPT are noticeably larger (>11 kDa) than those from bacteria such as Orf2, CloQ, NovQ, and Fnq26. This change may have occurred during enzyme evolution, possibly suggesting a different mode of substrate binding in fungal PTs. However, only substrate binding in bacterial PT Orf2 has been investigated by x-ray crystallography, and a fungal PT crystal structure remains unavailable (29). Herein, site-directed mutagenesis indirectly provided evidence that a different substrate binding mode is present in MaPT. In PT Orf2, the β-phosphate of GSPP was tethered in the network formed by Lys-119, Asn-173, Arg-228, and Tyr-282 while its -phosphate interacted with Tyr-216, Lys-284, and cofactor Mg²⁺. A group of similar amino acid residues were found in CloQ, NovQ, and Fnq26 for β-phosphate binding (supplemental Fig. S4). A positive charged residue such as Lys and Arg in these enzymes, corresponding to Ser-51 of Orf2 (supplemental Fig. S4), was suggested to act as surrogate for Mg²⁺ in -phosphate binding (21, 29). In MaPT, Lys-189, Lys-261, Tyr-325, and Tyr-394 were in the positions corresponding to those of Orf2 for β-phosphate binding (supplemental Fig. S4). Mutating both Lys-189 and Lys-261 to Glu and Leu confirmed the critical roles of these residues in enzyme catalysis (Fig. 5). The role of Lys-189 might be partially compensated by other proximal (basic) residues in the mutants, which made them partially active. However, Thr-105 instead of a basic residue in MaPT was in the same position as Ser-51 in PT Orf2, suggesting a different mode for -phosphate binding (Fig. S4). Moreover, this residue is conserved in many fungal PTs (data not shown). Although Thr-105 may not play the same role as other positive charged residues or Mg²⁺, it is still an important residue for enzyme catalysis (Fig. 5). The nearly complete loss of activity of MaPT T105D reflected the importance of a hydrophobic side chain in this position. Thr-105 in MaPT may be responsible for binding of hydrophobic DMAPP because Ser-51 is also close to the GSPP-binding pocket in the Orf2 crystal structure. One Asp residue is conserved among bacterial PTs and MaPT in amino acid sequence alignment analysis (supplemental Fig. S4). Although Asp-110 in Orf2 is involved in metal binding, the role of this acidic residue is not established in other PTs that are metal ion cofactor-independent. In the mutagenesis study, side chain hydrophilicity of Asp-179 was important for enzyme activity since D179V contained the lowest enzyme catalysis among the three mutants. The side chain length was also found to be important by comparing activities of wild-type enzyme and its D179E mutant. Thus, mutagenesis demonstrated that MaPT has a different binding mode of isoprene compared with bacterial PTs and revealed two important residues (Thr-105 and Asp-179) for enzyme activity.

The new class of PTs is comprised of several members including CloQ and TdiB (17, 23). Most of these enzymes have been identified by searching putative PT genes in databases containing microbial genome sequences. The studies herein provide an alternative strategy to identify new members of this class of PTs. Through designing degenerate primers and performing TAIL-PCR, the MaPT gene was isolated from genomic DNA of the recently isolated fungus, M. aurantiaca RRC1813. This enzyme encoded by the MaPT cDNA was characterized in detail to reveal substrate selectivity, kinetic parameters and optimal reaction conditions. In addition, two inhibitors (D-Trp and EDTA) were identified toward MaPT, representing two small molecules capable of affecting the activity of enzymes in this new class. Mutagenesis studies of four key residues in MaPT confirmed the putative role of Lys-189 and Asn-261 in substrate binding and assigned additional functions to Thr-105 and Asp-179 in enzyme catalysis, providing additional insights into this class of enzymes. Also, the high catalytic efficiency of MaPT suggests that it might become a useful tool in synthetic biology, and chemoenzymatic assembly of prenylated indole derivatives, which may be precursors for a number of complex biologically active molecules.

	FOOTNOTES

 
The nucleotide sequence(s) reported in this paper has been submitted to the Gen-Bank^TM/EBI Data Bank with accession number(s) EU420001 [GenBank] and EU420002.

^* This work was supported, in whole or in part, by National Institutes of Health Grant CA070375 (to R. M. W.). This work was also supported by the Hans W. Vahlteich Professorship (to D. H. S.), and an Eli Lilly & Company pre-doctoral fellowship (to Y. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental data, Figs. S1-S5, and Tables S1 and S2.

¹ To whom correspondence should be addressed: Life Sciences Institute and Dept. of Medicinal Chemistry, University of Michigan, 210 Wash-tenaw Ave, Ann Arbor, MI 48109-2216. Tel.: 734-615-9907; E-mail: davidhs{at}lsi.umich.edu.

² The abbreviations used are: PT, prenyltransferase; MaPT, prenyltransferase from M. aurantiaca; BME, β-mercaptoethanol; DHPTA, 1,3-diamino-2-propanol-N,N,N',N'-tetraacetic acid; DMATS, dimethylallyltryptophan synthase; DMAT, dimethylallyltryptophan; DMA5HT, dimethylallyl 5-OH-L-Trp; DMA5MT, dimethylallyl 5-Me-DL-Trp; DMAA, dimethylallyl L-abrine; HRMS, high resolution MS analysis; ICP-MS, inductively coupled plasma mass spectrometry; IPTG, isopropyl-1-thio-β-D-galactopyranoside; NTA, nitrilotriacetic acid.

	ACKNOWLEDGMENTS

 
We thank Dr. Anthony E. Glenn at the USDA for providing the M. aurantiaca RRC1813 strain. Dr. Douglas A. Burr is gratefully acknowledged for assistance with NMR and useful comments on the manuscript. We thank Paul Cipriani for preparation of media for growing E. coli and fungal strain.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 

1. Keller, N. P., Turner, G., and Bennett, J. W. (2005) Nat. Rev. Microbiol. 3, 937-947[CrossRef][Medline] [Order article via Infotrieve]
2. Gin, A. S., and Zhanel, G. G. (1996) Ann. Pharmacol. 30, 615-624[Abstract]
3. Walsh, C. (2003) Nat. Rev. Microbiol. 1, 65-70[CrossRef][Medline] [Order article via Infotrieve]
4. Spurgeon, D. (2007) Bmj. 335, 961[Free Full Text]
5. Pelaez, F. (2005) in Handbook of Industrial Mycology (An, Z. ed), Marcel Dekker, New York
6. Chiung, Y. M., Fujita, T., Nakagawa, M., Nozaki, H., Chen, G. Y., Chen, Z. C., and Nakayama, M. (1993) J. Antibiot. (Tokyo) 46, 1819-1826[Medline] [Order article via Infotrieve]
7. Martinez-Luis, S., Gonzalez, M. C., Ulloa, M., and Mata, R. (2005) Phytochemistry 66, 1012-1016[CrossRef][Medline] [Order article via Infotrieve]
8. Martinez-Luis, S., Rodriguez, R., Acevedo, L., Gonzalez, M. C., Lira-Rocha, A., and Mata, R. (2006) Tetrahedron 62, 1817-1822[CrossRef]
9. Schlegel, B., Hanel, F., Gollmick, F. A., Saluz, H. P., and Grafe, U. (2003) J. Antibiot. (Tokyo) 56, 917-922[Medline] [Order article via Infotrieve]
10. Schlegel, B., Hartl, A., Gollmick, F. A., and Grafe, U. (2003) J. Antibiot. (Tokyo) 56, 792-794[Medline] [Order article via Infotrieve]
11. Liang, P. H., Ko, T. P., and Wang, A. H. (2002) Eur. J. Biochem. 269, 3339-3354[Medline] [Order article via Infotrieve]
12. Walsh, C. T. (2007) ACS Chem. Biol. 2, 296-298[CrossRef][Medline] [Order article via Infotrieve]
13. Chen, A., Kroon, P. A., and Poulter, C. D. (1994) Protein Sci. 3, 600-607[Medline] [Order article via Infotrieve]
14. Wu, Z., Demma, M., Strickland, C. L., Radisky, E. S., Poulter, C. D., Le, H. V., and Windsor, W. T. (1999) Biochemistry 38, 11239-11249[CrossRef][Medline] [Order article via Infotrieve]
15. Wildung, M. R., and Croteau, R. (1996) J. Biol. Chem. 271, 9201-9204[Abstract/Free Full Text]
16. Starks, C. M., Back, K., Chappell, J., and Noel, J. P. (1997) Science 277, 1815-1820[Abstract/Free Full Text]
17. Balibar, C. J., Howard-Jones, A. R., and Walsh, C. T. (2007) Nat. Chem. Biol. 3, 584-592[CrossRef][Medline] [Order article via Infotrieve]
18. Edwards, D. J., and Gerwick, W. H. (2004) J. Am. Chem. Soc. 126, 11432-11433[CrossRef][Medline] [Order article via Infotrieve]
19. Gebler, J. C., and Poulter, C. D. (1992) Arch. Biochem. Biophys. 296, 308-313[CrossRef][Medline] [Order article via Infotrieve]
20. Grundmann, A., and Li, S. M. (2005) Microbiology 151, 2199-2207[Abstract/Free Full Text]
21. Haagen, Y., Unsold, I., Westrich, L., Gust, B., Richard, S. B., Noel, J. P., and Heide, L. (2007) FEBS Lett. 581, 2889-2893[CrossRef][Medline] [Order article via Infotrieve]
22. Kremer, A., Westrich, L., and Li, S. M. (2007) Microbiology 153, 3409-3416[Abstract/Free Full Text]
23. Pojer, F., Wemakor, E., Kammerer, B., Chen, H., Walsh, C. T., Li, S. M., and Heide, L. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 2316-2321[Abstract/Free Full Text]
24. Steffan, N., Unsold, I. A., and Li, S. M. (2007) Chembiochem. 8, 1298-1307[CrossRef][Medline] [Order article via Infotrieve]
25. Unsold, I. A., and Li, S. M. (2005) Microbiology 151, 1499-1505[Abstract/Free Full Text]
26. Unsold, I. A., and Li, S. M. (2006) Chembiochem. 7, 158-164[CrossRef][Medline] [Order article via Infotrieve]
27. Yin, W. B., Ruan, H. L., Westrich, L., Grundmann, A., and Li, S. M. (2007) Chembiochem. 8, 1154-1161[CrossRef][Medline] [Order article via Infotrieve]
28. Ohara, K., Yamamoto, K., Hamamoto, M., Sasaki, K., and Yazaki, K. (2006) Plant Cell Physiol. 47, 581-590[Abstract/Free Full Text]
29. Kuzuyama, T., Noel, J. P., and Richard, S. B. (2005) Nature 435, 983-987[CrossRef][Medline] [Order article via Infotrieve]
30. Sambrook, J., and Russel, D. W. (2001) Molecular Cloning - A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York
31. Liu, Y. G., and Whittier, R. F. (1995) Genomics 25, 674-681[CrossRef][Medline] [Order article via Infotrieve]
32. Shah, M. M., Grover, T. A., Barr, D. P., and Aust, S. D. (1992) J. Biol. Chem. 267, 21564-21569[Abstract/Free Full Text]
33. Bhattacharyya, D. K., Adak, S., Bandyopadhyay, U., and Banerjee, R. K. (1994) Biochem. J. 298, 281-288[Medline] [Order article via Infotrieve]
34. Carvajal, N., Orellana, M. S., Borquez, J., Uribe, E., Lopez, V., and Salas, M. (2004) J. Inorg. Biochem. 98, 1465-1469[CrossRef][Medline] [Order article via Infotrieve]
35. Cress, W. A., Chayet, L. T., and Rilling, H. C. (1981) J. Biol. Chem. 256, 10917-10923[Abstract/Free Full Text]
36. Tsai, H. F., Wang, H., Gebler, J. C., Poulter, C. D., and Schardl, C. L. (1995) Biochem. Biophys. Res. Commun. 216, 119-125[CrossRef][Medline] [Order article via Infotrieve]
37. Lam, K. S. (2007) Trends Microbiol. 15, 279-289[CrossRef][Medline] [Order article via Infotrieve]
38. Peraica, M., Radic, B., Lucic, A., and Pavlovic, M. (1999) Bull. World Health Organ. 77, 754-766[Medline] [Order article via Infotrieve]
39. Chan, H. T., and Anthony, C. (1992) FEMS Microbiol. Lett. 75, 231-234[Medline] [Order article via Infotrieve]
40. Gebler, J. C., Woodside, A. B., and Poulter, C. D. (1992) J. Am. Chem. Soc. 114, 7354-7360[CrossRef]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				O. Rigbers and S.-M. Li Ergot Alkaloid Biosynthesis in Aspergillus fumigatus: OVERPRODUCTION AND BIOCHEMICAL CHARACTERIZATION OF A 4-DIMETHYLALLYLTRYPTOPHAN N-METHYLTRANSFERASE J. Biol. Chem., October 3, 2008; 283(40): 26859 - 26868. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Supplemental Data All Versions of this Article: 283/23/16068    most recent M801991200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ding, Y. Articles by Sherman, D. H. Search for Related Content PubMed PubMed Citation Articles by Ding, Y. Articles by Sherman, D. H. Social Bookmarking                      What's this?